| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |